Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
Role of FCγRIIIA and FCγRIIA Receptor Polymorphisms
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2013-04-10
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 121
- Registration Number
- NCT01827956
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Aquitaine, France
Phase III Trial Evaluating the Effectiveness of a Dose Adjustment of Imatinib Mesylate on the Molecular Response
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 68
- Registration Number
- NCT01827930
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Aquitaine, France
Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 56
- Registration Number
- NCT01754597
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, Aquitaine, France
Validation of a Screening Tool in Geriatric Oncology
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 1674
- Registration Number
- NCT00963911
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Efavirenz in Treating Patients With Metastatic Prostate Cancer
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 61
- Registration Number
- NCT00964002
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
Phase 2
- Conditions
- First Posted Date
- 2009-08-24
- Last Posted Date
- 2010-04-07
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 72
- Registration Number
- NCT00964171
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2022-06-14
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 67
- Registration Number
- NCT00911183
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2021-02-24
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 120
- Registration Number
- NCT00871858
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
- First Posted Date
- 2008-10-03
- Last Posted Date
- 2021-01-26
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 18
- Registration Number
- NCT00766142
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 78
- Registration Number
- NCT00712712
- Locations
- 🇫🇷
Institute Bergonié, Bordeaux, France
© Copyright 2024. All Rights Reserved by MedPath